Oncosil Medical Ltd (ASX:OSL) has announced that a patient with pancreatic cancer was able to reduce their tumor through treatment with the company’s eponymous device in conjunction with chemotherapy during a procedure in Türkiye. Following successful treatment with the OncoSil device – together with chemotherapy – the patient’s tumor was reduced to a level which enabled surgical resection, and this surgery was carried out by Professor Dr. Koray Acarli, a renowned specialist in pancreatic cancer. Oncosil noted that the successful treatment represented a milestone in proving the device’s effica…